0001179110-22-001841.txt : 20220301
0001179110-22-001841.hdr.sgml : 20220301
20220301181420
ACCESSION NUMBER: 0001179110-22-001841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220225
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gosebruch Henry O
CENTRAL INDEX KEY: 0001659625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 22700264
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2022-02-25
0
0001551152
AbbVie Inc.
ABBV
0001659625
Gosebruch Henry O
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
EVP, Chief Strategy Officer
Common Stock, $0.01 par value
2022-02-25
4
F
0
30156
149.54
D
56623
D
Common Stock, $0.01 par value
2022-03-01
4
S
0
5596
147.5369
D
51027
D
Common Stock, $0.01 par value
2022-03-01
4
S
0
8303
148.6224
D
42724
D
Common Stock, $0.01 par value
2022-03-01
4
S
0
1101
149.1441
D
41623
D
Common Stock, $0.01 par value
78500
I
In trust
Common Stock, $0.01 par value
3457
I
Profit sharing trust
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.89 to $147.88 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.94 to $148.93 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.95 to $149.40 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.
Balance in AbbVie Savings program as of January 31, 2022.
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Henry O. Gosebruch
2022-03-01